G vs. EXE.TO

Last updated Jun 10, 2026

G (Genpact Limited) and EXE.TO (Extendicare Inc.) are both stocks. G operates in Information Technology Services (Technology), while EXE.TO operates in Medical Care Facilities (Healthcare). Over the past 10 years, G returned 2.67%/yr vs 21.30%/yr for EXE.TO. At a 0.21 correlation, their price movements are largely independent.

Performance

G vs. EXE.TO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Genpact Limited (G) and Extendicare Inc. (EXE.TO). The values are adjusted to include any dividend payments, if applicable.

Different Trading Currencies

G is traded in USD, while EXE.TO is traded in CAD. To make them comparable, the EXE.TO values have been converted to USD using the latest available exchange rates.

Returns By Period

In the year-to-date period, G achieves a -29.90% return, which is significantly lower than EXE.TO's 52.85% return. Over the past 10 years, G has underperformed EXE.TO with an annualized return of 2.67%, while EXE.TO has yielded a comparatively higher 21.30% annualized return.

G

• 1D: 0.71%
• 1M: 0.21%
• YTD: -29.90%
• 6M: -28.34%
• 1Y: -23.21%
• 3Y*: -3.22%
• 5Y*: -5.10%
• 10Y*: 2.67%

EXE.TO

• 1D: 0.34%
• 1M: -3.30%
• YTD: 52.85%
• 6M: 44.59%
• 1Y: 133.52%
• 3Y*: 70.93%
• 5Y*: 35.89%
• 10Y*: 21.30%

*Multi-year figures are annualized to reflect compound growth (CAGR)

G vs. EXE.TO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
G Genpact Limited	-29.90%	10.56%	25.78%	-23.98%	-11.74%	29.51%	-0.93%	57.66%	-14.12%	31.54%
EXE.TO Extendicare Inc.	52.85%	118.08%	42.81%	22.21%	-9.59%	17.32%	-12.84%	47.00%	-31.83%	4.30%

Correlation

The correlation between G and EXE.TO is -0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.10
Correlation (3Y) Calculated over the trailing 3-year period	0.14
Correlation (5Y) Calculated over the trailing 5-year period	0.21
Correlation (10Y) Calculated over the trailing 10-year period	0.22
Correlation (All Time) Calculated using the full available price history since Aug 2, 2007	0.21

The correlation between G and EXE.TO shifts across timeframes, from -0.10 (1 year) to 0.22 (10 years), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap G : $5.64B EXE.TO : CA$3.18B
EPS G : $3.25 EXE.TO : CA$1.37
PE Ratio G : 10.04 EXE.TO : 24.08
PEG Ratio G : 0.56 EXE.TO : 0.33
PS Ratio G : 1.11 EXE.TO : 1.68
PB Ratio G : 2.28 EXE.TO : 8.10
Total Revenue (TTM) G : $5.16B EXE.TO : CA$1.75B
Gross Profit (TTM) G : $1.87B EXE.TO : CA$553.60M
EBITDA (TTM) G : $844.98M EXE.TO : CA$205.13M

Return for Risk

G vs. EXE.TO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

G

G Risk / Return Rank: 15
G Sharpe Ratio Rank: 14
G Sortino Ratio Rank: 14
G Omega Ratio Rank: 15
G Calmar Ratio Rank: 23
G Martin Ratio Rank: 9

EXE.TO

EXE.TO Risk / Return Rank: 98
EXE.TO Sharpe Ratio Rank: 98
EXE.TO Sortino Ratio Rank: 99
EXE.TO Omega Ratio Rank: 98
EXE.TO Calmar Ratio Rank: 98
EXE.TO Martin Ratio Rank: 98

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

G vs. EXE.TO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Genpact Limited (G) and Extendicare Inc. (EXE.TO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	G	EXE.TO	Difference
Sharpe ratio: Return per unit of total volatility	-0.67	3.95	-4.62
Sortino ratio: Return per unit of downside risk	-0.86	5.60	-6.46
Omega ratio: Gain probability vs. loss probability	0.89	1.69	-0.79
Calmar ratio: Return relative to maximum drawdown	-0.58	8.98	-9.56
Martin ratio: Return relative to average drawdown	-1.41	26.69	-28.09
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

G vs. EXE.TO - Sharpe Ratio Comparison

The current G Sharpe Ratio is -0.67, which is lower than the EXE.TO Sharpe Ratio of 3.95. The chart below compares the historical Sharpe Ratios of G and EXE.TO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	G	EXE.TO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.67	3.95	-4.62
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.18	1.44	-1.62
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.10	0.81	-0.71
Sharpe Ratio (All Time) Calculated using the full available price history	0.19	0.34	-0.15

Drawdowns

G vs. EXE.TO - Drawdown Comparison

The maximum G drawdown since its inception was -64.14%, smaller than the maximum EXE.TO drawdown of -82.31%. Use the drawdown chart below to compare losses from any high point for G and EXE.TO.

Drawdown Indicators

	G	EXE.TO	Difference
Max Drawdown Largest peak-to-trough decline	-64.14%	-82.31%	+18.17%
Max Drawdown (1Y) Largest decline over 1 year	-40.04%	-14.95%	-25.09%
Max Drawdown (3Y) Largest decline over 3 years	-46.85%	-26.03%	-20.82%
Max Drawdown (5Y) Largest decline over 5 years	-46.85%	-30.02%	-16.83%
Max Drawdown (10Y) Largest decline over 10 years	-49.47%	-50.96%	+1.49%
Current Drawdown Current decline from peak	-40.07%	-5.13%	-34.94%
Average Drawdown Average peak-to-trough decline	-15.52%	-24.50%	+8.98%
Ulcer Index Depth and duration of drawdowns from previous peaks	16.54%	5.02%	+11.52%

Volatility

G vs. EXE.TO - Volatility Comparison

Genpact Limited (G) has a higher volatility of 13.70% compared to Extendicare Inc. (EXE.TO) at 11.60%. This indicates that G's price experiences larger fluctuations and is considered to be riskier than EXE.TO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	G	EXE.TO	Difference
Volatility (1M) Calculated over the trailing 1-month period	13.70%	11.60%	+2.10%
Volatility (6M) Calculated over the trailing 6-month period	27.09%	23.81%	+3.28%
Volatility (1Y) Calculated over the trailing 1-year period	34.96%	34.03%	+0.93%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	28.66%	25.00%	+3.66%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	28.14%	26.58%	+1.56%

Dividends

G vs. EXE.TO - Dividend Comparison

G's dividend yield for the trailing twelve months is around 2.14%, more than EXE.TO's 1.55% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
EXE.TO Extendicare Inc.	1.55%	2.34%	4.52%	6.59%	7.32%	6.58%	7.23%	5.69%	7.56%	5.25%	4.86%	4.97%
G Genpact Limited	2.14%	1.45%	1.42%	1.58%	1.08%	0.81%	0.94%	0.81%	1.11%	0.76%	0.00%	0.00%

Financials

G vs. EXE.TO - Profitability Comparison

The chart below illustrates the profitability comparison between Genpact Limited and Extendicare Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

G - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Genpact Limited reported a gross profit of 471.67M and revenue of 1.30B. Therefore, the gross margin over that period was 36.4%.

EXE.TO - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Extendicare Inc. reported a gross profit of 58.87M and revenue of 465.22M. Therefore, the gross margin over that period was 12.7%.

G - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Genpact Limited reported an operating income of 198.58M and revenue of 1.30B, resulting in an operating margin of 15.3%.

EXE.TO - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Extendicare Inc. reported an operating income of 42.70M and revenue of 465.22M, resulting in an operating margin of 9.2%.

G - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Genpact Limited reported a net income of 147.99M and revenue of 1.30B, resulting in a net margin of 11.4%.

EXE.TO - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Extendicare Inc. reported a net income of 40.73M and revenue of 465.22M, resulting in a net margin of 8.8%.

Frequently Asked Questions

Can I hold both G and EXE.TO in my portfolio?

G and EXE.TO have a correlation of -0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.